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Volume 49, Number 5S Plenary Sessions 11Sscores were 89.1 and 89.5. On average, an integrated applicant had pub-
lished 2.8 peer-reviewed publications.
Conclusion: The number of talented and motivated integrated appli-
cants far outweighs the number of available positions. Growing interest in
more efficient and comprehensive training will continue to augment de-
mand. As educators, vascular surgeons should seize this opportunity and
aggressively expand the number of available positions.
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Celia V Riga, Colin D Bicknell, Mohamad S Hamady, Nicholas J Cheshire.
St Mary’s Hospital, Imperial College Healthcare NHS Trust, London,
United Kingdom
Backround: Advances in stent graft technology have allowed the
treatment of complex thoraco-abdominal aneurysm disease via a total endo-
vascular approach but the procedure can be technically challenging and time
consuming.
Methods: A 4-vessel fenestrated stent graft partially deployed within a
CT-reconstructed pulsatile Type-II thoraco-abdominal aneurysm silicon
model was used. Twelve vascular specialists were asked to cannulate the renal
and visceral vessels under fluoroscopic guidance, using conventional and
robotic techniques. Quantitative (catheterization times and wire/catheter
tip movements) and qualitative metrics (validated procedure-specific-rating
scale (IC3ST), which grades operators on catheter use, instrumentation,
successful cannulation/catheterisation and overall performance assessed by
two blinded observers (Cronbach’s 0.94)) were compared (Wilcoxon
signed-rank test).
Results: Median procedure times for cannulation of all 4 vessels were
reduced using robotic catheters (2.9min IQR(2.3-4.2) versus 14min(11.1-
19.6); p0.002). The total number of wire/catheter movements taken to
complete the task was also significantly reduced (38 IQR(27.3-64.8) versus
423(221-662); p0.002). There were significant differences in time and
movement for cannulation of each individual vessel in the phantom. Roboticcatheter operator radiation exposure was minimal. Procedure-specific per-
formance scores were significantly improved with robotic catheterization
despite minimal operator exposure (IC3ST score 29/35 IQR(21.8-30.6)
versus 18.8/35 (11.5-24.1); p0.006).
Conclusions: Robotic catheterisation of target vessels during this
procedure is feasible and minimises radiation exposure for the operator.
Steerable robotic catheters with intuitive control may overcome some of the
limitations of standard catheter technology, enhance target vessel cannula-
tion, reduce instrumentation and improve overall performance scores.
Author Disclosures: C.V. Riga, None; C.D. Bicknell, None; M.S.
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Protamine Reduces Bleeding Complications Associated With Carotid
Endarterectomy Without Increasing the Risk of Stroke
David H. Stone1, Brian W. Nolan1, Andres Schanzer2, Philip P Goodney1,
Robert A. Cambria3, Donald S. Likosky1, Daniel B.Walsh1, Jack L. Cronen-
wett1, for the Vascular Study Group of NorthernNew England (VSGNNE).
1Dartmouth Hitchcock Medical Center, Lebanon, NH; 2University of
Massachusetts Medical School, Worcester, MA; 3Eastern Maine Medical
Center, Bangor, ME
Objectives: Controversy exists about whether protamine given during
carotid endarterectomy (CEA) prevents bleeding or increases thrombotic
complications such as stroke or myocardial infarction (MI). The purpose of
this study was to determine the effect of protamine reversal of heparin
anticoagulation on the outcome of CEA.
Methods: A prospective regional registry in Northern New England of
4,712 patients undergoing CEA by 66 surgeons from 11 centers from
2003-2008, was reviewed. Protamine use varied by surgeon (38% routine
use, 44% rare use, 18% variable use). The primary endpoint was postopera-
tive bleeding requiring reoperation. Secondary endpoints included stroke,
death and MI. Predictors of endpoints were determined by univariate
analysis using Pearson chi-square (Fisher’s exact correction) andmultivariate
logistic regression.
Results: Among 4712 patients undergoing CEA, 46% received prota-
mine while 54% did not. Patients who did not receive protamine had a
2.6-fold increase in reoperation for bleeding (Table). Protamine use did not
affect the rate of stroke, death, or MI. By multivariate analysis, protamine
reduced bleeding complications after accounting for other potential predic-
tors of bleeding including center variation, surgical technique, and antiplate-
let therapy; (OR 0.43, 95% CI 0.18-0.98, P.05). Consequences of reop-
eration for bleeding were a 7-fold increase in stroke, a 30-fold increase in
death and a 4-fold increase in MI.
Conclusion: Protamine reduces serious bleeding complications during
CEA without increasing the risk of stroke, death, or MI. Thus, protamine is
both safe and beneficial during CEA as practiced in this large, prospective
registry. In light of substantial complications referable to bleeding, liberal
use of protamine during CEA appears warranted.
N
Reoperation
For bleeding Stroke Death MI
Protamine 2180 14 (0.64%) 17 (0.78%) 5 (0.23%) 24 (1.1%)
No Protamine 2532 42 (1.66%) 29 (1.15%) 8 (0.32%) 23 (0.91%)
Chi-square P0.001 P0.20 P0.57 P0.51
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Carotid Endarterectomy In Female Patients: Subsets Of Patients At
Higher Surgical Risk
Walter Dorigo1, JohnMarek2, Raffaele Pulli1, Alessandro Alessi Innocenti1,
Giovanni Pratesi3, Carlo Pratesi1. 1University of Florence, florence, Italy;
2University of NewMexico, Albuquerque, NM; 3University of Tor Vergata,
Rome, ItalyObjectives:To evaluate early and late results of carotid endarterectomy
(CEA) in female patients in a large single center experience.
